- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03642925
Efficacy of Balanced Nutrition Meal Replacement Along With a Caloric Restriction on Body Weight Control (nutrition)
August 20, 2018 updated by: Chin Kun Wang, Chung Shan Medical University
The present study was designed to evaluate the impact of a nutritionally balanced conventional meal replacement diet with caloric restriction (intervention for 8 weeks) in Taiwanese obese subjects.
Various parameters like anthropometric (body weight, body fat, waist circumference), lipid profile (TC, LDL-c and TG), cardiovascular risk factors, glycemic and oxidative markers as well as renal and hepatic markers were evaluated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The present study was designed to evaluate the impact of a nutritionally balanced conventional meal replacement diet (rich in soy/pea protein and soluble fibers) with caloric restriction in Taiwanese obese subjects.
Obese subjects (BMI>27; n=50, male 23, female 27) were recruited and requested to replace two meals/day (breakfast and lunch or dinner) by balanced nutritional meal replacement diet (equal to 240 kcal) for 8 weeks with one regular meal and make sure the daily target calorie limit should be less than 1500 kcal/day for men and 1200 kcal/day for women.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Taichung
-
Taichung city, Taichung, Taiwan, 40201
- Chung Shan Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy obese subject (BMI >27)
- Aged between 20 to 80 of both genders with a desire to lose weight.
Exclusion Criteria:
- Subjects with cancer
- Hyperglycemic (diabetic)
- Hypertension,
- Stroke
- Renal dysfunction
- Cardiac or hepatic dysfunctio
- allergic to the dairy product and eating disorders
- Pregnancy, nursing (lactating), chain smokers and heavy alcoholic subjects
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Meal replacement diet
Obese subjects (BMI>27; n=50, male 23, female 27) were requested to replace (intervention) two meals/day (breakfast and lunch or dinner) by balanced nutritional meal replacement diet (equal to 240 kcal) for 8 weeks
|
Obese subjects were requested to replace two meals/day (breakfast and lunch or dinner) by balanced nutritional meal replacement diet (equal to 240 kcal) for 8 weeks with one regular meal and make sure the daily target calorie limit should be less than 1500 kcal/day for men and 1200 kcal/day for women.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Calorie intake in obese subjects
Time Frame: 8 weeks
|
Intervention with calorie restricted meal replacement diet for 8 weeks to check the changes in calories (Kcal)
|
8 weeks
|
Anthropometric parameter
Time Frame: 8 weeks
|
Intervention with calorie restricted meal replacement diet for 8 weeks to check the change in body weight (kg)
|
8 weeks
|
Anthropometric parameter
Time Frame: 8 Weeks
|
Intervention with calorie restricted meal replacement diet for 8 weeks to check the change in BMI (Kg/m2)
|
8 Weeks
|
Cardiovascular (CV) risk factors
Time Frame: 8 Weeks
|
Intervention with calorie restricted meal replacement diet for 8 weeks to check the changes in CV risk factor like Homocysteine (umol/L)
|
8 Weeks
|
Glycemic markers
Time Frame: 8 Weeks
|
Intervention with calorie restricted meal replacement diet for 8 weeks to check the changes in Glycemic marker like FBG (mg/dL)
|
8 Weeks
|
Lipid profile
Time Frame: 8 weeks
|
Intervention with calorie restricted meal replacement diet for 8 weeks to check the changes in total cholesterol (mg/dl)
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 21, 2015
Primary Completion (ACTUAL)
January 21, 2016
Study Completion (ACTUAL)
March 1, 2016
Study Registration Dates
First Submitted
August 10, 2018
First Submitted That Met QC Criteria
August 20, 2018
First Posted (ACTUAL)
August 22, 2018
Study Record Updates
Last Update Posted (ACTUAL)
August 22, 2018
Last Update Submitted That Met QC Criteria
August 20, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CS15124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Meal replacement diet
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedObesity | Weight Loss | DietNetherlands
-
Guangdong Provincial Hospital of Traditional Chinese...Recruiting
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.Recruiting
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.RecruitingBody Weight | Overweight and ObesityCroatia
-
Khoo Teck Puat HospitalCompletedThe Effect of Intermittent Energy Restriction Using Meal Replacements in Overweight Chinese SubjectsObesity | FastingSingapore
-
University of North Carolina, Chapel HillCompletedOverweight | Obese | Body Composition, Beneficial | Satiety | Basal Metabolic RateUnited States
-
West German Center of Diabetes and HealthAlmased Wellness GmbHCompleted
-
Johns Hopkins Bloomberg School of Public HealthMedifast, Inc.CompletedObesity | Type 2 Diabetes Mellitus
-
Teatis, IncCitruslabsNot yet recruitingDiabetes Mellitus, Type 2United States